Inflectra (infliximab-dyyb), 2nd Biosimilar Approved in US

The Biosimilar market got a significant boost this week as the FDA approved Inflectra (infliximab-dyyb) which is a biosimilar to Janssen Biotech’s Remicade (infliximab) on April 5th 2016. Celltrion manufactures Inflectra for Hospira, and is now approved for the following indications in the US: Crohn’s disease Ulcerative colitis Rheumatoid arthritis in combination with methotrexate Ankylosing spondylitis […]

Meet the Experts at IMCAS Paris 2016

IMCAS World Congress 2016 January 28th to 31st, Paris Meet Deirdre Kelly, PhD at IMCAS where the newest advancements in aesthetic surgery & cosmetic dermatology will be discussed. The highly exciting cosmeceutical market will also be a key area that is presented. Among the presentations, Deirdre is particularly interested in the following events: M&A dynamics and […]

Meet Deirdre at MAP 2015 Molecular Analysis for Personalised Therapy

The first Molecular Analysis for Personalised therapy (MAP) meeting will be held in Paris, Oct 23/24 2015 and is organised by UNICANCER, ESMO and Cancer Research UK. I’m looking forward to hearing expert opinions on the clinical interpretation of molecular tests for metastatic cancers and specifically the following talks: Beyond driver identification: what can we […]

1st Frontiers in IL-17 Meeting – Trinity College and Novartis

Meet Deirdre at the 1st Frontiers in IL-17 meeting held at the Science Gallery, Trinity College Dublin on Sept 4th 2015. In partnership with Novartis, this symposium aims to tackle the therapeutic potential of IL-17 signalling targets in autoimmune disorders such as Psoriasis, Crohn’s Disease and Rheumatoid Arthritis. There is a significant economic and patient burden […]

PRESS RELEASE: Cutting-edge new research by KellySciPub indicates that the core personalized medicine market will be worth over $60 billion by 2019.

  Cutting-edge new research by KellySciPub indicates that the core personalized medicine market will be worth over $60 billion by 2019. This market is made up of companion diagnostics and targeted therapeutics and is currently worth $42 billion. This market is dominated by oncology, cardiovascular and infectious disease treatment and diagnostics. The report ‘Personalized Medicine, […]

Press Release World Cosmetic Surgery and Service Market to Reach USD 27 Bln by 2019, States Kelly Scientific Publications in Its Report Available at MarketPublishers.com

http://www.ssuchronicle.com/2015/03/16/world-cosmetic-surgery-and-service-market-to-reach-usd-27-bln-by-2019-states-kelly-scientific-publications-in-its-report-available-at-marketpublishers-com New research report “Global Cosmetic Surgery and Service Market Report 2015-2019” elaborated by Kelly Scientific Publications is available at MarketPublishers.com. The global cosmetic surgery and service market is predicted to climb to USD 27 billion by 2019. London, UK (PRWEB) March 16, 2015 The global cosmetic surgery and service market is currently estimated at […]

New Report Offering – Global Cosmetic Surgery and Services Market 2015-2019

Global Cosmetic Surgery & Services Market Analysis 2015-2019 Published March 2015 Cosmetic Surgery sample pages KellySciPub’s cutting-edge report Global Cosmetic Surgery & Services Market Analysis 2015-2019 is the latest analysis on this vertically growing market. It is currently worth over $20 billion and is set to rise to over $27 billion by 2019.  This comprehensive […]

Joint International Personalized Medicine & Cancer Biomarker Summit 2015

Joint International Personalized Medicine & Cancer Biomarker Summit 2015 June 16-17 2015 London, UK Pinnacle Intelligence is proudly hosting the ‘Personalized Medicine & Cancer Biomarker Summit’ June 16-17 2015, London, UK. This international meeting will bring together investors, pharma and biotech professionals, medical professionals, research scientists and key players within the industry. The main goal of […]